Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWindar Photo Regulatory News (WPHO)

Share Price Information for Windar Photo (WPHO)

Share Price is delayed by 15 minutes
Get Live Data
27.25    0.50 (1.87%)
Bid:
26.50
Ask:
28.00
Spread: 1.50 (5.66%)
Market Cap: £26.77m
WPHO Live PriceLast checked at - London Stock Exchange

Intraday Windar Photo Share Chart

Trading Statement

23 Dec 2025 07:00

RNS Number : 5654M
Windar Photonics PLC
23 December 2025
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

23 December 2025

 

("Windar" or the "Company")

Trading Update

 

Windar Photonics plc (AIM: WPHO), the technology group behind the LiDAR-assisted monitoring and optimisation solution for multiple wind turbine platforms, provides the following update on current trading and strategic progress.

Current trading

For the 12 months to 31 December 2025 (FY 2025) the Company now expects record revenue of between €6.5m and €6.8m, representing growth of approximately 45% over 2024. With an improved gross margin, EBITDA is expected to be neutral, compared with a loss in the prior year.Although the FY 2025 turnover will be a record for the Company and reflects the considerable potential of the business, it is nonetheless short of our expectations* due to a delay in finalising an order in China with a significant gross value. At this point in its rapid development, the Company remains sensitive to large single orders affecting growth forecasts and this order, for which products are ready to ship, will now move into FY 2026.

Overall, demand for Windar's technology continues to strengthen as customer awareness increases of its ability to improve wind turbine power output by 2-4%, delivering a typical ROI within just two years.

\* The Company believes consensus market expectations for FY 2025 to be for Revenues of €9.45m and EBITDA of €2.2m

Growth Activities

As Windar transitions from a small to a significantly larger business, the Company has focused on strengthening its operational, commercial and manufacturing capabilities to support both current demand and future growth. During FY 2025, the Company has made the following strategic progress:

· Successfully concluded new orders for test projects in North America and Germany across Senvion, Vestas, Siemens and General Electric turbine platforms, which augurs well for FY 2026 and beyond

· Opened a new, future-proof manufacturing facility, increasing production capacity five-fold

· Appointed new Vice Presidents of Sales for Europe and North America in August and September respectively

· Established an Advisory Board comprising leading figures from the global wind industry

· Windar's products are now expected to be installed on approximately 25% of all V82 turbines in North America

Jørgen Korsgaard Jensen, Chief Executive, commented:

"Clear commercial interest from both existing and new customers underpins Windar's considerable future potential. Over 12 months ago, we recognised the need to expand our operational base and capacity in multiple areas if we were going to achieve this potential. We have now done much of this work.

The tests completed on new turbines in North America and Germany bode well for the business and with the manufacturing capacity now in place to deliver to meet increased sales, together with our balance sheet strength, the business is well placed to grow again in 2026."

 

For further information, please contact:

Windar Photonics plc

Jørgen Korsgaard Jensen, CEO

Søren Belmar, CFO

Tel: +45 24234930

Tel: +45 53527276

Zeus (Nominated Adviser and Broker)

David Foreman /James Bavister

Tel: +44 (0) 20 3829 5000

Novella Communications

Tim Robertson / Safia Colebrook

Tel: +44 (0) 20 3151 7008

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMZZZZLGKZZ
Date   Source Headline
3rd Jun 202611:54 amRNSCEO Appointment, Grant of Options and RPT
28th May 202610:45 amRNSCorrection: Director/PDMR Shareholding
21st Apr 20267:00 amRNSCEO Appointment
20th Apr 202612:15 pmRNSHolding(s) in Company
20th Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update & £20m Share Subscription Facility
26th Mar 20261:30 pmRNSIssue of Equity in Lieu of Non-Executive Fees
16th Jan 20266:22 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirectorate change
23rd Dec 20257:00 amRNSTrading Statement
23rd Dec 20257:00 amRNSTrading Statement
15th Dec 20257:00 amRNSChange of Adviser
13th Nov 20259:41 amRNSHolding(s) in Company
20th Oct 20257:00 amRNSDirectorate Change
15th Sep 20257:00 amRNSHalf-year Report
8th Sep 20257:00 amRNS-RSenior Management Appointment
13th Aug 20257:00 amRNS-RSenior Management Appointment
11th Aug 20257:00 amRNSNew $2.6m Order For The US Market
1st Aug 202512:27 pmRNSResult of AGM
1st Aug 20257:00 amRNSAGM Statement
1st Jul 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNSUpdate on Expectations
9th Jun 20257:00 amRNSDirectorate Change
19th May 20257:00 amRNS-RWindar Photonics to Exhibit at CLEANPOWER 2025
30th Apr 20257:00 amRNSWind Sector Leaders Join New Advisory Board
14th Apr 20257:00 amRNSDirector/PDMR Shareholding
26th Mar 20255:19 pmRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSTrading Update and First Discreet Software Order
26th Feb 202512:41 pmRNSIssue of Equity in Lieu of Directors' Fees
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSMaterial New US Order
10th Dec 20242:30 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:41 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:31 pmRNSTR-1: Notification of Major Holdings
3rd Dec 20248:00 amRNSResult of oversubscribed placing
2nd Dec 20244:35 pmRNSProposed placing to raise £5.5 million
12th Nov 20247:00 amRNSTrading Update
19th Sep 20245:34 pmRNSAIM Rule 17 Schedule 2 (G) Update
12th Sep 20247:00 amRNSUn-audited Results for the 6 months ended 30 June
5th Aug 20244:52 pmRNSResults of AGM
5th Aug 20247:00 amRNSAGM Trading Update
1st Aug 202410:44 amRNSAppointment of Broker
19th Jul 202410:36 amRNSDirectorate Change and Director Disclosures
15th Jul 20247:00 amRNSChange of Nominated Adviser
11th Jul 20249:13 amRNSPosting of Annual Report and Notice of AGM
4th Jul 20245:33 pmRNSAIM Rule 17 Schedule 2 (G) Update
1st Jul 20247:00 amRNSAudited Results, Trading Update and Notice of AGM
3rd May 202410:37 amRNSDirectors Dealing / PDMR Shareholding
22nd Apr 20249:38 amRNSDirector Dealing
18th Apr 20245:30 pmRNSDirector dealing / PDMR shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.